Xbiotech Inc (XBIT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 91,051 | 57,329 | 7,244 | 0 | N/A |
| Other current assets | 0 | 324 | 0 | 0 | 0 |
| TOTAL | $93,041 | $58,064 | $7,693 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 5,946 | 3,227 | 3,380 | 0 | N/A |
| Other Non-Current Assets | 10,371 | 886 | 0 | 0 | 0 |
| TOTAL | $16,317 | $4,113 | $3,380 | $N/A | $N/A |
| Total Assets | $109,358 | $62,177 | $11,073 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,825 | 1,629 | 561 | 0 | 0 |
| Accrued Expenses | 1,466 | 1,518 | 284 | 0 | N/A |
| TOTAL | $6,291 | $3,147 | $845 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 17 | 0 | 0 | 0 | 0 |
| TOTAL | $17 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,308 | $3,147 | $845 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 32,292 | N/A | N/A | N/A | N/A |
| Common Shares | 233,902 | 152,351 | 81,807 | 0 | N/A |
| Retained earnings | -130,651 | -93,168 | -71,444 | 0 | N/A |
| Other shareholders' equity | -201 | -153 | -135 | 0 | 0 |
| TOTAL | $103,050 | $59,030 | $10,228 | $0 | $N/A |
| Total Liabilities And Equity | $109,358 | $62,177 | $11,073 | $0 | $0 |